BLOG

Limits of NK Cell Therapy: What to Ask Before Considering It in Osaka

Published 2026.10.09 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

When people research cancer immune cell therapy online, they often find enthusiastic descriptions of what the treatment aims to do. Far fewer pages explain what it cannot do. For patients who are travelling from abroad or living in Japan as foreign residents, an honest picture of the limits is just as important as an explanation of the mechanism. This article looks at the boundaries of NK cell therapy so that you can arrive at a consultation with realistic expectations and better questions.

The short answer: a treatment option to understand, not a promise

NK cell therapy is an immune cell therapy in which a patient’s own natural killer cells are collected from a blood draw, activated and expanded at a specialised facility, and returned by intravenous infusion. The aim is to support immune function that may have weakened. It is not a guarantee of any particular outcome, and it is not a replacement for standard cancer treatment. Whether it is appropriate for you depends on your diagnosis, your current treatment and your general condition, and that judgement belongs to a doctor who has examined you.

Grand Green Osaka Umekita Clinic in Osaka offers NK cell therapy as a self-pay (non-insured) treatment, and the clinic provides information pages in several languages for international patients. The points below are meant to help you decide what to ask, not to predict what any individual person will experience.

Why the evidence is still developing

NK cells are innate immune cells that can recognise and attack abnormal cells without waiting for instructions from other parts of the immune system. This is why researchers have studied them for many years as a possible way to support the body against cancer. Published studies of NK cell infusions exist, and the field is active, but results vary by cancer type, by how the cells are prepared and by the clinical setting. Early-phase studies often focus on feasibility and tolerability rather than on proving long-term benefit.

For that reason, a careful reader should be cautious about any claim that sounds definitive. A single study, however encouraging, does not settle how a therapy performs across different patients. You can reasonably ask a doctor which published research is relevant to your situation, how strong that evidence is, and where the uncertainty remains.

What NK cell therapy does not replace

Standard treatments such as surgery, chemotherapy and radiation therapy remain the foundation of cancer care for most people. NK cell therapy is described as something that may be used alongside them, because it is generally considered unlikely to interfere with those treatments, and the clinic can coordinate with the medical institution providing your standard care. That is a very different idea from using it instead of them. If you are considering this therapy, keep your primary oncology team informed and ask them how they view the timing.

It is also worth remembering that individual responses differ. Factors such as age, the type and stage of disease, previous treatments and overall immune function can all influence how a person responds. No page on the internet can tell you which group you fall into.

Side effects, risks and legal framework

Because the therapy uses your own cells, the risk of rejection is considered low, and serious side effects have rarely been reported. Even so, temporary fever or fatigue may occur, and no medical procedure is free of risk. A blood draw and an infusion also carry the ordinary small risks that come with any needle-based procedure.

In Japan, treatments of this kind are provided under the Act on the Safety of Regenerative Medicine, which requires a treatment plan to be reviewed by a certified committee and submitted to the Ministry of Health, Labour and Welfare and requires cell processing to be carried out at appropriately licensed facilities. This framework supports oversight, but it does not mean that a treatment is approved as an insured standard therapy or that its effectiveness has been established. Ask the doctor to explain which plan covers the therapy you are being offered and what monitoring is in place.

Practical limits for international patients

NK cell therapy is a self-pay treatment in Japan, so it is not covered by national health insurance, and your overseas insurer may not reimburse it either. Costs, the number of sessions and the overall treatment period should be confirmed in writing at the time of consultation rather than assumed from a website. The treatment involves the collection of blood, a period of cell preparation and then infusion, so the schedule needs to be planned carefully if you are travelling to Osaka.

Follow-up is another practical point. If you return home between visits, think about who will monitor your health, how test results will be shared and how your home physician will stay informed. Language support matters here, and it is reasonable to ask how interpretation and written explanations are handled.

Questions to bring to your consultation

A clear list of questions can make a first consultation far more useful. Consider asking the following.

Based on my diagnosis and current treatment, is NK cell therapy a reasonable option to discuss, and why?
What evidence supports its use in my situation, and what is uncertain?
How would it fit alongside the treatment I am already receiving?
What are the possible side effects and risks, and how will they be monitored?
What are the total costs, the number of sessions and the expected timeline?
What happens if I decide to stop, and how will follow-up be arranged after I return home?

Bring recent medical records, imaging reports and a list of current medicines, and consider sharing your plans with your home oncologist. A good consultation should leave you better informed, whatever you decide.

Summary

NK cell therapy works with a patient’s own immune cells and may be an option worth knowing about, but it has genuine limits. The evidence is still developing, responses differ between individuals, it does not replace standard cancer treatment, and it is a self-pay therapy provided under Japan’s regenerative medicine law. The most useful step is a face-to-face or online consultation in which a doctor reviews your situation, explains the risks, side effects and costs, and answers your questions honestly. Grand Green Osaka Umekita Clinic can be contacted to discuss whether such a consultation makes sense for you.

Before you consider NK therapy

Evidence still developingResults vary by patient
Not a replacementUsed alongside standard care
Self-pay treatmentConfirm costs in writing
Ask your doctorRisks, side effects, timeline

This diagram is a conceptual summary of the article content

Learn more about NK Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›